Update on antiobesity pharmacotherapy in adults: Current and emerging options.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 41482465.
- Also identified by DOI 10.3949/ccjm.93a.24112.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Obesity is a chronic disease that increases the risk of developing other serious health conditions. Pharmacotherapy can help patients effectively manage obesity by achieving a healthier weight, but each antiobesity medication has its own benefits and risks that must be evaluated for each patient. This article reviews the available antiobesity medications, including the incretin mimetics, and emerging antiobesity medications currently under investigation.
Medical subject headings
- Anti-Obesity Agents
- Obesity